<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="792990" id="root" date="1997-08-12" xml:lang="en">
<title>USA: TABLE - Human Genome Sciences Q2 shr $0.13.</title>
<headline>TABLE - Human Genome Sciences Q2 shr $0.13.</headline>
<dateline>ROCKVILLE, Md. 1997-08-12</dateline>
<text>
<p>SELECTED FINANCIAL DATA</p>
<p>			 Three Months Ended     Six Months Ended</p>
<p>		    06/30/97     06/30/96    06/30/97    06/30/96</p>
<p>				(In thousands, except per share data)</p>
<p>Statement of Operations Data:</p>
<p>Revenue-Research and</p>
<p>development</p>
<p>Collaborative contract</p>
<p>  revenue	  $14,828	$13,050     $16,100	26,984</p>
<p>Costs and expenses:</p>
<p>Research and development:</p>
<p>Direct expenditures</p>
<p>			 9,043	  6,978	17,951	13,469</p>
<p>Payments under research</p>
<p>services agreement</p>
<p>			 2,655	  2,513	 6,119	 5,034</p>
<p>General and</p>
<p>  administrative   2,898	  2,379	 5,287	 4,402</p>
<p>Total costs and expenses</p>
<p>			14,596	 11,870	29,357	22,905</p>
<p>Net interest income</p>
<p>			 2,886	  1,500	 4,334	 2,978</p>
<p>Income (loss)</p>
<p>  before taxes     3,118	  2,680     (8,923)	 7,057</p>
<p>Provision for income taxes</p>
<p>			   245	     51	   245	   141</p>
<p>Net income (loss)</p>
<p>			 2,873	  2,629     (9,168)	 6,916</p>
<p>Net income (loss) per share</p>
<p>			  0.13	   0.13	(0.44)	  0.35</p>
<p>Weighted average number</p>
<p>  of shares   22,723,247   19,599,038  20,770,145  19,537,641</p>
<p>				    Jun 30, 1997	   Dec 31, 1996</p>
<p>Balance Sheet Data:</p>
<p>Cash, cash equivalents and</p>
<p>  short-term investments (1)    $209,980		 $117,821</p>
<p> Total assets			  243,553		  140,117</p>
<p>Total debt and capital leases,</p>
<p>  less current portions		2,668		    2,954</p>
<p> Total stockholders' equity	232,300		  128,521</p>
<p>(1) Includes $1,417 and  1,705 in restricted cash at June 30, 1997 and</p>
<p>December 31, 1996, respectively</p>
<p>SOURCE  Human Genome Sciences, Inc.</p>
<p>-- New York Newsdesk 212 859-1610</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-08-12"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-08-12"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C15">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-08-12"/>
  </code>
  <code code="C151">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-08-12"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-08-12"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-08-12"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-08-12"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="ROCKVILLE, Md."/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
